跳至主要内容
临床试验/NCT02440776
NCT02440776Unknown不适用

Pathway CH S&E Registry: Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache - ATI Neurostimulation System is Branded Internationally as Pulsante™ Microstimulator System

Autonomic Technologies, Inc.9 个研究点 分布在 5 个国家目标入组 30 人开始时间: 2015年4月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
9
主要终点
Characterization of all device/procedure related Adverse Events

研究概览

简要总结

Monitor the safety and performance of the Pulsante Microstimulator System.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient meets CE marked labeling for cluster headache.
  • Patient has the ability to read, comprehend and reliably record information as required by the Protocol.
  • Patient is able to provide written informed consent prior to participation in the study.

排除标准

  • Patient has other significant pain problem that might confound the study assessments in the opinion of the Investigator.

结局指标

主要结局

Characterization of all device/procedure related Adverse Events

时间窗: Through five years post implant

Outcome will be assessed at Implant, 3, 6, 9, 12, 18, 24, 36, 48 and 60 months post implant.

次要结局

  • Acute response to therapy(Through five years post implant)

研究者

发起方
Autonomic Technologies, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验